Kovitz Investment Group Partners, LLC Moderna, Inc. Transaction History

Kovitz Investment Group Partners, LLC

$15 Billion
Q3 2024

A detailed history of Kovitz Investment Group Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 48,763 shares of MRNA stock, worth $1.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

48,763

Previous 47,079 3.58%

Holding current value

$1.8 Million

Previous $5.59 Million 41.72%

% of portfolio

0.02%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $107,169 - $210,735	1,684 Added 3.58%	48,763 $3.26 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $1.16 Million - $1.92 Million	11,510 Added 32.36%	47,079 $5.59 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $96,468 - $130,447	1,130 Added 3.28%	35,569 $3.79 Million
Q4 2023 Feb 07, 2024	SELL	$69.51 - $104.43 $250,583 - $376,470	-3,605 Reduced 9.48%	34,439 $3.42 Million
Q3 2023 Nov 09, 2023	SELL	$96.41 - $126.61 $156,859 - $205,994	-1,627 Reduced 4.1%	38,044 $3.93 Million
Q2 2023 Aug 08, 2023	SELL	$118.5 - $160.53 $240,436 - $325,715	-2,029 Reduced 4.87%	39,671 $4.82 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $61,589 - $89,447	454 Added 1.1%	41,700 $6.4 Million
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $110,922 - $196,807	937 Added 2.32%	41,246 $7.41 Million
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $8,973 - $14,757	76 Added 0.19%	40,309 $4.77 Million
Q2 2022 Aug 02, 2022	BUY	$117.13 - $176.59 $106,822 - $161,050	912 Added 2.32%	40,233 $5.75 Million
Q1 2022 Apr 22, 2022	BUY	$126.46 - $235.05 $4.97 Million - $9.24 Million	39,321 New	39,321 $6.77 Million
Q3 2021 Oct 28, 2021	SELL	$221.9 - $484.47 $234,548 - $512,084	-1,057 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$129.91 - $234.98 $137,314 - $248,373	1,057 New	1,057 $248,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.

Account

Kovitz Investment Group Partners, LLC Moderna, Inc. Transaction History